AMOYTOP(SH:688278) Zheng Quan Zhi Xing·2025-05-22 12:36Group 1 - The core point of the report is the equity change of Xiamen Te Bao Biological Engineering Co., Ltd., where Tibet Trust Co., Ltd. (representing "Tibet Trust - Jintong No. 35 Collective Fund Trust Plan") has acquired 23,187,600 shares, increasing its stake to 5.70% of the total share capital [1][7][16] - The equity change is based on a share transfer agreement signed on May 22, 2025, at a price of 56.12 RMB per share, totaling approximately 1.301 billion RMB [6][8][16] - The report confirms that the equity change has been authorized and complies with relevant laws and regulations, and it has been disclosed in accordance with the requirements of the Securities Law of the People's Republic of China [2][5] Group 2 - The purpose of the equity change is to gain confidence in the company's future development and long-term investment value [6] - The information disclosure obligor has no specific plans to increase its holdings in the next 12 months and commits to a lock-up period of 12 months post-transfer [6][16] - The report states that there are no restrictions on the transferred shares, and the shares are free from any pledges or freezes [12][16]